Pure Global AI
Finland flag

Finland medical device registration timeline

Source-linked clocks

Finnish Medicines Agency (Fimea) review clocks and end-to-end planning ranges, using the 4-class (I, IIa, IIb, III) — EU MDR classification system.

1 pathways1 of 1 clocks verifiedvalidity 5 years (CE certificate)MDSAP not acceptedreviewed 2026-08-29eur-lex.europa.eu
Class / pathwayReview clockPlanning totalWith prior approvalProvenance
Class I(Self-declaration (no notified body))
MDR Art. 52(7): non-sterile, non-measuring, non-reusable-surgical Class I devices are self-declared, so no authority or notified body reviews the file and there is no review clock
0 days6-9 monthsVerified
Review clocks exclude applicant hold time · planning totals are estimates

Finland Medical Device Registration Process

Step-by-step Fimea registration process. Total estimated timeline: 6-9 months.

Step 1: Pre-Submission Preparation

1-3 months

Gather technical documentation, quality management system (QMS) records, and clinical data required by Fimea. Appoint a EU Authorized Representative.

Step 2: Application Submission

1-2 weeks

Submit complete registration dossier to Fimea including device description, risk analysis, and testing reports.

Step 3: Administrative Review

2-4 weeks

Fimea reviews application for completeness. May request additional documents or clarifications.

Step 4: Technical Evaluation

0 days

In-depth technical assessment of device safety and performance. Fimea may issue questions.

Step 5: Registration Approval

1-2 weeks

Upon successful review, Fimea issues Finland market authorization certificate.

Summary: The Finland medical device registration process through Finnish Medicines Agency (Fimea) consists of 5 main steps: Pre-Submission Preparation → Application Submission → Administrative Review → Technical Evaluation → Registration Approval.
Prior approval recognition
FDA 510(k)/PMANo substitute for EU MDR conformity assessment; useful as predicate documentation in the technical file
Key requirements
  • EU Authorized Representative (for non-EU manufacturers)
  • National registration is notification-only: no statutory review clock; data recorded in the national register (CERE reference / EUDAMED Actor ID after registration) (49 § 12 mom. Law 719/2021)
  • Clinical investigation IIa/IIb: authorisation notified within 45 days of validation (+20 with experts) (21 § 4 mom.); validation: Fimea checks 10 days, applicant clarifications 10 days, re-check 5 days
  • Class-I (Art. 62) studies start upon validation notice; Art. 82: decision within 65 days; class-I-type devices start 25 days after submission / 5 days after clarifications
  • Substantial modifications implementable if not prohibited within 45 days / 10 days after clarifications; Art. 74(1) studies notified at least 30 days before start; IVDR Art. 58(2) studies notified at least 10 days before start
Primary regulator sources

Reviewed 2026-08-29. End-to-end totals remain planning estimates.

Keep researching this market
View the Finland resource hub →
Compare timeline across all countries →
Source-linked review clocks verified against Fimea publications · full review 2026-08-29 · row IDs are stable — cite as registration-timeline:finland:class-i